Elevated Capital Advisors LLC Acquires 14,043 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Elevated Capital Advisors LLC raised its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 35.5% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 53,605 shares of the pharmacy operator’s stock after purchasing an additional 14,043 shares during the quarter. Elevated Capital Advisors LLC’s holdings in Walgreens Boots Alliance were worth $480,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. New Covenant Trust Company N.A. bought a new stake in shares of Walgreens Boots Alliance in the 1st quarter valued at $35,000. Iron Horse Wealth Management LLC increased its position in shares of Walgreens Boots Alliance by 162.5% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 1,300 shares in the last quarter. FinTrust Capital Advisors LLC increased its position in shares of Walgreens Boots Alliance by 60.4% in the 1st quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock valued at $46,000 after buying an additional 802 shares in the last quarter. Blue Trust Inc. increased its position in shares of Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 1,081 shares in the last quarter. Finally, Continuum Advisory LLC increased its position in shares of Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,020 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Evercore ISI increased their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. JPMorgan Chase & Co. lowered their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Royal Bank of Canada lowered their target price on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a report on Tuesday, July 2nd. Finally, Bank of America lowered their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a report on Wednesday, September 4th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $12.88.

Walgreens Boots Alliance Trading Down 3.9 %

Shares of NASDAQ:WBA opened at $9.35 on Thursday. Walgreens Boots Alliance, Inc. has a 52-week low of $8.22 and a 52-week high of $27.05. The company has a market capitalization of $8.07 billion, a P/E ratio of -1.39, a price-to-earnings-growth ratio of 1.37 and a beta of 0.70. The company has a 50-day simple moving average of $9.37 and a 200 day simple moving average of $12.91. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.31 and a current ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same period last year, the business posted $0.67 EPS. Walgreens Boots Alliance’s revenue was up 5.9% on a year-over-year basis. Sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.57 earnings per share for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.